{"entity":{"type":"insider","cik":"0001257544","url":"/insider/0001257544","json_url":"/insider/0001257544.json","name":"PRYGOCKI MARK A SR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":5,"first":"2004-02-12","last":"2011-05-18","span_basis":"filed_date"},"name_variants":[{"name":"PRYGOCKI MARK A SR","source":"filing","n_filings":5,"first_seen":"2004-02-12","last_seen":"2011-05-18"}],"transactions":[{"id":9028254,"accession":"0001246360-11-002534","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001246360-11-002534","line_url":"/filing/0001246360-11-002534#line-3","is_derivative":false,"issuer_cik":"0000859368","issuer_name":"MEDICIS PHARMACEUTICAL CORP","issuer_ticker":"MRX","issuer_name_source":null,"issuer_url":"/issuer/0000859368","owner_cik":"0001257544","owner_name":"PRYGOCKI MARK A SR","owner_display_name":"PRYGOCKI MARK A SR","owner_url":"/insider/0001257544","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67591.0,"shares_display":"67,591","price_per_share":36.7599,"price_display":"36.76","price_state":"stated","total_value":2484638.4009,"total_display":"2,484,638.40","total_whole":"2,484,638","shares_owned_after":281617.0,"shares_owned_after_display":"281,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-16","filed_date":"2011-05-18","scope":"insider"},{"id":7225359,"accession":"0001246360-10-003038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001246360-10-003038","line_url":"/filing/0001246360-10-003038#line-2","is_derivative":false,"issuer_cik":"0000859368","issuer_name":"MEDICIS PHARMACEUTICAL CORP","issuer_ticker":"MRX","issuer_name_source":null,"issuer_url":"/issuer/0000859368","owner_cik":"0001257544","owner_name":"PRYGOCKI MARK A SR","owner_display_name":"PRYGOCKI MARK A SR","owner_url":"/insider/0001257544","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114986.0,"shares_display":"114,986","price_per_share":26.27,"price_display":"26.27","price_state":"stated","total_value":3020682.22,"total_display":"3,020,682.22","total_whole":"3,020,682","shares_owned_after":246442.0,"shares_owned_after_display":"246,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-12","filed_date":"2010-08-16","scope":"insider"},{"id":5599737,"accession":"0001246360-09-001772","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001246360-09-001772","line_url":"/filing/0001246360-09-001772","is_derivative":false,"issuer_cik":"0000859368","issuer_name":"MEDICIS PHARMACEUTICAL CORP","issuer_ticker":"MRX","issuer_name_source":null,"issuer_url":"/issuer/0000859368","owner_cik":"0001257544","owner_name":"PRYGOCKI MARK A SR","owner_display_name":"PRYGOCKI MARK A SR","owner_url":"/insider/0001257544","role":"Officer (EVP,COO)","role_mark":"O","role_mark_label":"Officer (EVP,COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10953.0,"shares_display":"10,953","price_per_share":15.01087921117502,"price_display":"15.01","price_state":"stated","total_value":164414.16,"total_display":"164,414.16","total_whole":"164,414","shares_owned_after":236526.0,"shares_owned_after_display":"236,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-15","filed_date":"2009-05-19","scope":"insider","n_lines":10},{"id":3910734,"accession":"0001246360-06-001520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001246360-06-001520","line_url":"/filing/0001246360-06-001520#line-1","is_derivative":false,"issuer_cik":"0000859368","issuer_name":"MEDICIS PHARMACEUTICAL CORP","issuer_ticker":"MRX","issuer_name_source":null,"issuer_url":"/issuer/0000859368","owner_cik":"0001257544","owner_name":"PRYGOCKI MARK A SR","owner_display_name":"PRYGOCKI MARK A SR","owner_url":"/insider/0001257544","role":"Officer (EVP,CFO Corp Sec/Treas)","role_mark":"O","role_mark_label":"Officer (EVP,CFO Corp Sec/Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,CFO Corp Sec/Treas","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":29.67,"price_display":"29.67","price_state":"stated","total_value":59340.0,"total_display":"59,340.00","total_whole":"59,340","shares_owned_after":42713.0,"shares_owned_after_display":"42,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-31","filed_date":"2006-06-01","scope":"insider"},{"id":623868,"accession":"0001209191-04-009084","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-04-009084","line_url":"/filing/0001209191-04-009084","is_derivative":false,"issuer_cik":"0000859368","issuer_name":"MEDICIS PHARMACEUTICAL CORP","issuer_ticker":"MRX","issuer_name_source":null,"issuer_url":"/issuer/0000859368","owner_cik":"0001257544","owner_name":"PRYGOCKI MARK A SR","owner_display_name":"PRYGOCKI MARK A SR","owner_url":"/insider/0001257544","role":"Officer (CFO, Exec VP, Corp Sec, Treasr)","role_mark":"O","role_mark_label":"Officer (CFO, Exec VP, Corp Sec, Treasr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Exec VP, Corp Sec, Treasr","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115836.0,"shares_display":"115,836","price_per_share":38.40316102075348,"price_display":"38.40","price_state":"stated","total_value":4448468.56,"total_display":"4,448,468.56","total_whole":"4,448,469","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-02-10","filed_date":"2004-02-12","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000859368","name":"MEDICIS PHARMACEUTICAL CORP","url":"/issuer/0000859368","role":"Officer (President)","n_filings":5,"first_seen":"2004-02-12","last_seen":"2011-05-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001257544","retrieved_at":"2026-08-22T23:45:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}